Investigating the dosimetric and tumor control consequences of prostate seed loss and migration

Medical Physics

Volumn 39, Issue 6, 2012, Pages 3291-3298

  Knaup, Courtney ^a   Mavroidis, Panayiotis ^a,b   Esquivel, Carlos ^a   Stathakis, Sotirios ^a   Swanson, Gregory ^a   Baltas, Dimos ^c,d   Papanikolaou, Nikos ^a  

^a University of Texas Health Science Center   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Department of Medical Physics and Engineering Offenbach Clinic ^*  (Germany)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

brachytherapy; prostate; radiobiology

Indexed keywords

BIOLOGICAL RADIATION EFFECTS; DISEASES; DOSIMETRY; ONCOLOGY; RADIOTHERAPY; TUMORS;

BRACHYTHERAPY; LOW DOSE RATE BRACHYTHERAPY; PROSTATE; PROSTATE BRACHYTHERAPY; RADIOBIOLOGICAL EFFECTS; RADIOBIOLOGY; SUBSTANTIAL REDUCTION; TUMOR CONTROL PROBABILITY;

UROLOGY;

EID: 84863533302     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.4712227     Document Type: Article

References (21)

1. D. B. Fuller, J. A. Koziol, and A. C. Feng, Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors., Brachytherapy 3, 10-19 (2004). 10.1016/j.brachy.2004.02.003
2. S. Nag, D. D. Scaperoth, R. Badalament, S. A. Hall, and J. Burgers, Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration., Urology 45, 87-92 (1995). 10.1016/S0090-4295(95)96950-0
3. G. S. Merrick, W. M. Butler, A. T. Dorsey, J. H. Lief, and M. L. Benson, Seed fixity in the prostate/periprostatic region following brachytherapy., Int. J. Radiat. Oncol., Biol., Phys. 46, 215-220 (2000). 10.1016/S0360-3016(99)00405- 8
4. R. A. Older, B. Synder, T. L. Krupski, D. J. Glembocki, and J. Y. Gillenwater, Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy., J. Urol. 165, 1590-1592 (2001). 10.1016/S0022-5347(05)66354-9
5. S. Nag, D. Beyer, J. Friedland, P. Grimm, and R. Nath, American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer., Int. J. Radiat. Oncol., Biol., Phys. 44, 789-799 (1999). 10.1016/S0360-3016(99)00069-3
6. Y. Yu, L. L. Anderson, Z. Li, D. E. Mellenberg, R. Nath, M. C. Schell, F. M. Waterman, A. Wu, and J. C. Blasko, Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64., Med. Phys. 26, 2054-2076 (1999). 10.1118/1.598721
7. R. Nath, W. S. Bice, W. M. Butler, Z. Chen, A. S. Meigooni, V. Narayana, M. J. Rivard, and Y. Yu, AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group No. 137., Med. Phys. 36, 5310-5322 (2009). 10.1118/1.3246613
8. C. R. King, T. A. DiPetrillo, and D. E. Wazer, Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models., Int. J. Radiat. Oncol., Biol., Phys. 46, 165-172 (2000). 10.1016/S0360-3016(99)00406-X
9. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine., Med. Phys. 22, 209-234 (1995). 10.1118/1.597458
10. R. G. Dale, Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model., Br. J. Radiol. 62, 241-244 (1989). 10.1259/0007-1285-62-735-241
11. R. G. Dale and B. Jones, The clinical radiobiology of brachytherapy., Br. J. Radiol. 71, 465-483 (1998).
12. V. Antipas, R. G. Dale, and I. P. Coles, A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd., Phys. Med. Biol. 46, 2557-2569 (2001). 10.1088/0031-9155/46/10/304
13. J. Z. Wang, M. Guerrero, and X. A. Li, How low is the alpha/beta ratio for prostate cancer?, Int. J. Radiat. Oncol., Biol., Phys. 55, 194-203 (2003). 10.1016/S0360-3016(02)03828-2
14. A. Haworth, M. Ebert, D. Waterhouse, D. Joseph, and G. Duchesne, Assessment of i-125 prostate implants by tumor bioeffect., Int. J. Radiat. Oncol., Biol., Phys. 59, 1405-1413 (2004). 10.1016/j.ijrobp.2004.01.047
15. C. I. Armpilia, R. G. Dale, I. P. Coles, B. Jones, and V. Antipas, The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants., Int. J. Radiat. Oncol., Biol., Phys. 55, 378-385 (2003). 10.1016/S0360-3016(02)04208-6
16. C. S. Wuu and M. Zaider, A calculation of the relative biological effectiveness of 125I and 103Pd brachytherapy sources using the concept of proximity function., Med. Phys. 25, 2186-2189 (1998). 10.1118/1.598415
17. L. Strigari, L. C. Orlandini, I. Andriani, A. d'Angelo, M. Stefanacci, A. M. Di Nallo, and M. Benassi, A mathematical approach for evaluating the influence of dose heterogeneity on TCP for prostate cancer brachytherapy treatment., Phys. Med. Biol. 53, 5045-5059 (2008). 10.1088/0031-9155/53/18/013
18. L. Beaulieu, L. Archambault, S. Aubin, E. Oral, R. Taschereau, and J. Pouliot, The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs., Int. J. Radiat. Oncol., Biol., Phys. 58, 1298-1308 (2004). 10.1016/j.ijrobp.2003.11.016
19. Y. Su, B. J. Davis, M. G. Herman, A. Manduca, and R. A. Robb, Examination of dosimetry accuracy as a function of seed detection rate in permanent prostate brachytherapy., Med. Phys. 32, 3049-3056 (2005). 10.1118/1.2012789
20. P. L. Roberson, V. Narayana, D. L. McShan, R. J. Winfield, and P. W. McLaughlin, Source placement error for permanent implant of the prostate., Med. Phys. 24, 251-257 (1997). 10.1118/1.598058
21. M. Gao, J. Z. Wang, S. Nag, and N. Gupta, Effects of seed migration on post-implant dosimetry of prostate brachytherapy., Med. Phys. 34, 471-480 (2007). 10.1118/1.2409748